Cysitic Fibrosis and Improving Lung Health.
The Importance of Persistence—and Pulmozyme—Every Day
Considering Pulmozyme?
Don’t put it off—ask your doctor whether you can be doing more to delay disease progression with Pulmozyme. Learn More.
Using Pulmozyme?
Stay committed and proactive—With Pulmozyme, every day matters when it comes to lung health. Learn More
You must have Javascript enabled and Flash 8.0 or above to get the full Experience of Pulmozyme.com.
Please download Flash here
CF Living
Discover CF Living -
an email program designed to support you with tailored information to help you manage your journey with CF
Indication and Usage
Daily administration of Pulmozyme in conjunction with standard therapies is indicated in the management of cystic fibrosis (CF) patients to improve pulmonary function. In patients with an FVC ≥40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring parenteral antibiotics.
Safety and efficacy of daily administration have not been demonstrated in patients for longer than 12 months.
